Abstract
Background Obese children with asthma are more vulnerable to air pollution, especially fine particulate matter (PM2.5), but reasons are poorly understood. We hypothesised that differences in breathing patterns (tidal volume, respiratory rate and minute ventilation) due to elevated body mass index (BMI) may contribute to this finding.
Objective To investigate the association of BMI with breathing patterns and deposition of inhaled PM2.5.
Methods Baseline data from a prospective study of children with asthma were analysed (n=174). Tidal breathing was measured by a pitot-tube flowmeter, from which tidal volume, respiratory rate and minute ventilation were obtained. The association of BMI z-score with breathing patterns was estimated in a multivariable model adjusted for age, height, race, sex and asthma severity. A particle dosimetry model simulated PM2.5 lung deposition based on BMI-associated changes in breathing patterns.
Results Higher BMI was associated with higher tidal volume (adjusted mean difference (aMD) between obese and normal-range BMI of 25 mL, 95% CI 5–45 mL) and minute ventilation (aMD 453 mL·min−1, 95% CI 123–784 mL·min−1). Higher tidal volumes caused higher fractional deposition of PM2.5 in the lung, driven by greater alveolar deposition. This translated into obese participants having greater per-breath retention of inhaled PM2.5 (aMD in alveolar deposition fraction of 3.4%, 95% CI 1.3–5.5%), leading to worse PM2.5 deposition rates.
Conclusions Obese children with asthma breathe at higher tidal volumes that may increase the efficiency of PM2.5 deposition in the lung. This finding may partially explain why obese children with asthma exhibit greater sensitivity to air pollution.
Abstract
Changes in breathing patterns due to obesity may explain why obesity increases susceptibility to air pollution https://bit.ly/36768Pk
Introduction
Exposure to air pollution, particularly fine particulate matter with an aerodynamic diameter <2.5 µm (PM2.5), is harmful to pulmonary health [1–3]. In children, it is a known driver of chronic bronchitis, incident asthma and asthma exacerbation [4, 5].
Obesity may increase susceptibility to air pollution. Epidemiological associations between ambient air pollution and respiratory symptoms are stronger among obese versus normal-weight children and adults [6, 7]. Obese children with asthma report worse symptoms with equivalent levels of exposure to indoor PM2.5 and secondhand smoke [8, 9].
Increased susceptibility to equal indoor concentrations of PM2.5, via greater deposition of inhaled particles, is a potential pathway to at least partly explain disparate asthma morbidity in obese versus nonobese children. Bennett and Zeman [10] reported among 36 healthy children that obesity was associated with greater fractional deposition of inhaled particles in the respiratory system during tidal breathing, and that this relationship was most strongly related to obese children having higher tidal volumes. However, breathing patterns in children with asthma are unknown. Furthermore, changes in anatomic location of particle deposition within the respiratory system due to obesity have not been examined.
The objective of this study was to examine 1) the association of BMI to respiratory patterns; 2) the association of breathing patterns to PM2.5 particle deposition characteristics; and 3) the association of BMI to PM2.5 particle deposition characteristics within a cohort of children with asthma. We hypothesise that obese children with asthma will breathe at higher tidal volumes, that higher tidal volumes will translate to more efficient deposition of PM2.5 in the respiratory system and that obese children will therefore receive a greater “dose” of inhaled particles compared with normal-weight children.
Methods
Study cohort
AIRWEIGHS is a single-centre, randomised, parallel-assignment, quadruple-masked clinical trial of an air purifier intervention for obesity-associated asthma (NCT02763917). A pre-specified secondary objective of the study was to examine breathing patterns in normal-weight and obese children with asthma. Participants were aged 8–17 years, nonsmokers, and had physician-diagnosed asthma by National Asthma Education and Prevention Program (NAEPP) criteria with at least one exacerbation in the prior year [11]. Those who were underweight or had other significant cardiopulmonary disease were excluded. The study was approved by the institutional review board of Johns Hopkins University School of Medicine (IRB00074171). All participants gave assent, and all primary caretakers gave written informed consent.
Potential participants who lived within the Baltimore (MD, USA) region were identified from patients seen in Johns Hopkins outpatient clinics and the paediatric emergency department, community engagement activities, recruitment flyers posted in public locations and a registry of previous study participants. Enrolment was not explicitly stratified by obesity, as similar proportions of nonobese and obese children were anticipated based on historical recruitment data from our research centre. Baseline characterisation and measurement of breathing patterns occurred as part of the lead-in period prior to randomisation, and thus this study includes participants who were lost to follow-up or disenrolled prior to randomisation. A diagram of participant flow is included as supplementary figure E1.
Participant characterisation
Sociodemographic information was obtained by participant or caregiver report. Asthma control was represented by the maximum symptom day (the maximum of the number of days in the prior 2 weeks a participant had slowed activity, wheezing, or coughing or chest tightness due to asthma) and by the Asthma Therapy Assessment Questionnaire (ATAQ) score, which ranges from 0 to 4, with scores ≥1 indicating uncontrolled asthma [12, 13]. Body weight and height were measured in triplicate and each averaged, from which body mass index (BMI) was calculated and converted to a normalised z-score based on the 2000 Centers for Disease Control and Prevention (CDC) growth charts [14, 15]. We chose z-score instead of percentile due to substantial negative skew in the BMI percentile distribution from a high proportion of obese participants. Gravimetric concentration of PM2.5 in the participant's bedroom was measured by a personal environmental monitor (model 200; MSP Corporation, Shoreview, MN, USA) containing a 37-mm polytetrafluroethylene filter (Teflo R2PI025; Pall Corporation, New York, NY, USA) connected to a personal aerosol sampling pump (model AFC 400S; BGI Incorporated, Waltham, MA, USA) running at 4 L·min−1. Sampling was performed prior to randomisation for 1 week.
Breathing patterns
Up to 10 minutes of at-rest breathing was measured by a calibrated flowmeter while participants passively watched videos on a multimedia device [16]. The apparatus was comprised of a pitot-tube flow sensor connected to a full-face neoprene mask. The design allowed integrated continuous measurements of oral and nasal airflow, minimised mechanical dead space and allowed participants to breathe to their comfort.
Breath-by-breath tidal volume and respiratory rate were calculated from the airflow waveforms utilising a semi-automated time-series analysis (WaveMetrics; Portland, OR, USA), from which tidal volume and respiratory rate were measured. Minute ventilation was derived as the product of tidal volume and respiratory rate. More details are included in the supplementary material.
Particle deposition
We applied the multipath particle dosimetry (MPPD) model version 3.04 (Applied Research Associates, Raleigh, NC, USA) to estimate the effects of breathing patterns on PM2.5 deposition. This computational model estimates region-specific particle deposition characteristics in a five-lobe respiratory system by applying theoretical equations of particle impaction, sedimentation and diffusion, which are described in more detail elsewhere [17]. The model incorporates age-specific differences in airway morphometry originally described by Mortensen and co-workers [18, 19]. MPPD estimates have been shown to agree with empirical measurements of total deposition among individuals aged 3 months to 21 years, and it is a commonly used model in dosimetry research in children [20–22].
We input each participant's own tidal volume and respiratory rate into the model. Other parameters, chiefly body position and functional residual capacity (FRC), were left at default values. Estimates of fractional deposition (ratio of particles deposited to particles inhaled) and deposition rate (particle mass deposited per minute) for the upper respiratory tract (URT), defined as nose to trachea; tracheobronchial, defined as trachea to the 16th airway generation; and alveolar regions were calculated. To allow between-participant comparisons of deposition rate attributable to BMI, calculations of deposition rate assumed a constant indoor air PM2.5 concentration equal to the mean observed in-home concentration.
We performed sensitivity analysis of two key model assumptions. First, the model estimated participant FRC using an age-specific equation based on the work of Hoffman [23]. Because obesity in children is associated with a reduction in FRC, we performed a parallel analysis by forcing a 20% reduction in model-estimated FRC among obese participants, which is the approximate magnitude based on a meta-analysis of studies [24]. Second, due to lack of empirical data specifically for nasal deposition efficiency in children, the model assumed different values for nasal deposition efficiency among children aged <12, 12–15 and ≥16 years. We initially stratified estimates by age group and investigated if this assumption caused systematic differences in the relationship of BMI to deposition characteristics between age groups. After determining that they were not, unstratified estimates were reported. Further details are included in the supplementary material.
Statistical analysis
Univariable comparisons between obese and nonobese participants were performed with unpaired t-tests for continuous variables and Chi-squared tests for categorical variables. The association of BMI z-score with tidal volume, respiratory rate and minute ventilation was estimated by multivariable linear regression. We adjusted for covariates predictive of lung function (age, age2, height, height2, sex and race) as well as asthma severity by NAEPP criteria [25]. Because there was a nonlinear association between BMI z-score and respiratory rate, BMI was represented as a linear and squared term. Statistical association was assessed by a Wald test against the hypothesis that the coefficient of BMI z-score and BMI z-score2 were jointly equal to zero. Contrasts between an obese (BMI z-score of 2.2, corresponding to the median z-score among obese participants in this study) and normal weight participant (z-score of 0) were estimated. For deposition analysis, statistical relationships between BMI z-score, respiratory pattern and deposition pattern were estimated by univariable regression.
All statistical analyses were performed in Stata 15 (StataCorp, College Station, TX, USA). A two-sided p-value of <0.05 was considered statistically significant.
Results
Cohort description
174 participants had available anthropometry and respiratory pattern data for inclusion in this study (table 1). Mean age was 11 years, and the majority were of male sex and Black race. Despite most participants receiving moderate-to-high doses of inhaled corticosteroids, 81% of the 155 participants with recorded ATAQ scores had uncontrolled asthma. The mean in-home PM2.5 concentration was 20.1 μg·m−3. The BMI z-score range was −1.7 (5th percentile) to 2.9 (>99th percentile), and approximately half of the participants were obese by CDC criteria. When stratified by obesity, there were no differences in baseline characteristics in univariable comparisons, except for higher minute ventilation among obese participants.
Association of BMI with tidal volume, respiratory rate and minute ventilation
As shown in figure 1, we identified a linear relationship between increasing BMI and increasing tidal volume (adjusted mean difference (aMD) between obese and normal-range BMI of 25 mL, 95% CI 5–45 mL). Respiratory rate had a U-shaped relationship with BMI, with those at the extremes of observed values having higher respiratory rates. However, the magnitude of change in tidal volumes outweighed the change in respiratory rate, such that the relationship of BMI to minute ventilation remained approximately linear, with increasing BMI associated with increasing minute ventilation (aMD 453 mL·min−1, 95% CI 123–784 mL·min−1). A child at the 99th percentile for BMI (z-score of 2.2) was predicted to have ∼17% higher minute ventilation compared to a child at the 50th percentile (z-score of 0).
Tidal volume and respiratory rate have opposing effects on alveolar fractional deposition
MPPD analysis demonstrated that higher tidal volumes were associated with greater fractional deposition of inhaled PM2.5 within the respiratory system (supplementary figure E2). This was predominantly driven by more efficient deposition within the alveolar region, where for every 100-mL increase in tidal volume, fractional deposition in this region increased by ∼4% (supplementary figure E2). Associations with other regions are listed in supplementary table E1.
Higher respiratory rates were associated with the opposite effect. With increasing respiratory rate, total fractional deposition decreased (supplementary figure E3), which was again driven by decreased alveolar fractional deposition (supplementary figure E3). Higher respiratory rate was also statistically associated with lower fractional deposition in the tracheobronchial region and higher fractional deposition in the URT region, but these were of negligible magnitude (supplementary table E1).
Overall, the effect of obesity was an increase in total and alveolar fractional deposition (figure 2). An obese child was predicted to have a 12% higher alveolar fractional deposition compared to a normal-weight child, corresponding to an adjusted mean difference of 3.4% (95% CI 1.3–5.5%). We did not find a relationship between BMI and fractional deposition within the tracheobronchial or URT regions.
Next, we reduced FRC among obese participants and found that associations between BMI and worsened fractional deposition were maintained (supplementary figure E4). The difference in alveolar fractional deposition between an obese and normal-weight child was qualitatively similar at 5.2% (95% CI 2.7–7.7%). In more comprehensive sensitivity analyses (not shown), we found that inferences were insensitive to perturbations in FRC.
Obesity is associated with higher rates of particle deposition
We next modelled rates of PM2.5 deposition at a concentration of 24.1 μg·m−3 for each participant, the mean indoor PM2.5 concentration from the 148 available measurements in this cohort (supplementary figure E1). As shown in figure 3, higher BMI was strongly associated with higher rates of particulate deposition within the respiratory system. This was driven predominantly by higher rates of deposition within the alveolar region (figure 3), where an obese child was predicted to have a 29% higher rate of PM2.5 deposition compared to a normal-weight child, corresponding to an adjusted mean difference of 7.1 ng·min−1 (95% CI 3.9–10.2 ng·min−1), with smaller increases in deposition rates within the URT and tracheobronchial regions (supplementary table E2).
Discussion
In this study of children with asthma, we found positive associations between BMI and tidal volume, respiratory rate and minute ventilation. We identified that obesity was associated with higher tidal volume and higher minute ventilation, which were in turn associated with greater breath-to-breath efficiency and higher rate of PM2.5 deposition in the lung. These results provide evidence for a unique mechanism which may partially explain why obese children with asthma demonstrate greater susceptibility to air pollution.
To our knowledge, this is the first study to examine obesity-related changes in breathing patterns among children with asthma. The combination of obesity precipitating a higher respiratory rate, with each breath being more efficient in depositing PM2.5 in the lung, outlines a “dual hit” scenario whereby obese children with asthma are cumulatively exposed to greater amounts of airborne particulate matter than their normal-weight counterparts even when breathing the same ambient air.
Our results are consistent with a small experimental study in healthy children by Bennett and Zeman [10] showing that increased BMI was associated with higher total fractional deposition of inhaled fine particles, which was in turn most associated with higher tidal volumes. Our results extend this study by examining a larger number of children, focusing on those with prevalent asthma, and incorporating estimates of regional in addition to total fractional deposition. Additionally, we utilised a novel flowmeter that allowed direct measurement of both oral and nasal flows. This device increased ventilatory measurement accuracy by minimising mechanical dead space and avoided the need for a nose clip, which has been shown to alter breathing patterns [26].
We utilised the MPPD model to predict consequences of BMI-associated changes in breathing patterns, which to our knowledge is the first application of a dosimetry model for this purpose. In this manner, we were able to relate obesity to more deleterious particle deposition characteristics. We emphasise that this inference was made indirectly through an analysis of tidal volumes in silico. An implicit assumption in this approach is that the effect of obesity on particle deposition occurs predominantly through changes in breathing patterns. Although we showed that the model was not particularly sensitive to perturbations in FRC, and we did not identify any other configurable parameter that may be conceivably altered by obesity, our study should not be interpreted as conclusive. Direct physiological measurement of regional particle deposition characteristics in nonobese and obese children with asthma is an important next step.
Due to increased metabolism and carbon dioxide production, an increase in minute ventilation with higher BMI is perhaps unsurprising [10, 27]. However, our study suggests that this was due in part to an increase in tidal volume, which is not immediately intuitive. Among adults, obesity has been associated with lower tidal volumes at rest and exercise, findings attributed to decreased respiratory system compliance and differences in autonomic regulation of breath timing [27–30]. These would seem consistent with well-described associations of obesity with a restrictive pattern on pulmonary function testing, characterised by reduced total lung capacity (TLC), FRC and in cases of morbid obesity, a reduction in forced vital capacity (FVC). However, literature from adult bariatric studies have related weight-reduction surgery with a decrease in tidal volume despite an increase in FVC and reversal of other impairments seen in pulmonary function testing, reinforcing that lung function does not necessarily correlate with breathing patterns and suggesting that our finding may not be limited to children [31, 32]. Furthermore, in children, despite similar reductions in TLC and FRC, morbid obesity does not significantly affect FVC, suggesting that respiratory mechanics remain more preserved in the young [24].
An obese child at the 99th percentile for BMI was predicted to have a 29% higher rate of alveolar PM2.5 deposition compared to a normal-weight child at the 50th percentile. Although the extrapolated difference of 10.2 μg per day is small, this estimate is conservative as it assumes calm, tidal breathing in an indoor environment at modest concentrations of PM2.5. In children with asthma, small differences in indoor PM2.5 concentration are associated with large differences in asthma symptoms, highlighting that asthma control is especially sensitive to environmental changes [33]. This may be explained by the particular harms of PM2.5, which by virtue of their small size are able to deposit deeper within the respiratory tree, exposing a large surface area of airway epithelium to inflammatory injury [34].
The direct measurement of breathing patterns and application of the MPPD model to predict consequences of their changes due to obesity are key novelties of this investigation. However, some limitations are noted. Although we have shown that estimates from the MPPD model were robust to changes in assumed inputs, the model does not explicitly simulate airway obstruction. Howerer, this limitation is balanced by two factors. First, exposure studies of ultrafine particles in children and fine particles in adults have both shown that asthma is associated with higher total deposition, suggesting that our findings establish a conservative lower bound for estimates of fractional deposition [35, 36]. Second, almost all participants with asthma in these other studies had obstruction on spirometry. This was not evident in our population, making significant departures from MPPD estimates less likely overall. Additionally, because AIRWEIGHS did not recruit participants who are underweight, this study cannot be extrapolated to children below the 5th percentile for BMI. Finally, our study population was predominantly Black and recruited from an urban centre, with attendant limitations in generalisability to the overall population of paediatric asthma.
Conclusion
Among children with asthma, obesity was associated with higher tidal volumes which, in turn, was associated in a particle deposition model with more efficient deposition of PM2.5 within the lung generally and alveoli in particular. These findings characterise a mechanism for why obese children with asthma are more susceptible to air pollution, and thus rationale for why obesity is a risk factor for more severe and uncontrolled asthma. Follow-on investigation of particle deposition characteristics in children with asthma is warranted.
Supplementary material
Supplementary Material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Supplementary material ERJ-00209-2021.Supplement
Shareable PDF
Supplementary Material
This one-page PDF can be shared freely online.
Shareable PDF ERJ-00209-2021.Shareable
Footnotes
This article has an editorial commentary: https://doi.org/10.1183/13993003.02505-2021
Conflict of interest: N. Afshar-Mohajer has nothing to disclose.
Conflict of interest: T.D. Wu has nothing to disclose.
Conflict of interest: R. Shade has nothing to disclose.
Conflict of interest: E. Brigham reports grants from the National Institute for Environmental Health Sciences, during the conduct of the study.
Conflict of interest: H. Woo has nothing to disclose.
Conflict of interest: M. Wood has nothing to disclose.
Conflict of interest: R. Koehl has nothing to disclose.
Conflict of interest: K. Koehler has nothing to disclose.
Conflict of interest: J. Kirkness reports other (salary) from 4DMedical, outside the submitted work.
Conflict of interest: N.N. Hansel reports grants from NIH and COPD Foundation, grants and personal fees for advisory board work from AstraZeneca and GSK, grants from Boehringer Ingelheim, personal fees for advisory board work from Mylan during the conduct of the study.
Conflict of interest: G. Ramachandran has nothing to disclose.
Conflict of interest: M.C. McCormack reports grants from National Institutes of Health (P50ES018176) and Environmental Protection Agency (83615201), during the conduct of the study; other (authorship royalties) from UpToDate, personal fees for consultancy from Aridis, GlaxoSmithKline and Celgene, outside the submitted work.
Support statement: Technology described in this manuscript was supported by an SBIR award from the National Heart, Lung, and Blood Institute (R44HL091687). E. Brigham, K. Koehler, N.N. Hansel and M.C. McCormack are supported by the National Institute of Environmental Health Sciences (K. Koehler, N.N. Hansel and M.C. McCormack: P50ES018176; E. Brigham: K23ES029105) and by the United States Environmental Protection Agency (83615201 and 83615001). T.D. Wu is supported by the National Heart, Lung, and Blood Institute (K23HL151669) and by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Center for Innovation in Quality, Effectiveness and Safety (CIN 13-413). This work is the sole responsibility of the authors and does not necessarily represent the views of the National Institutes of Health, the Department of Veterans Affairs, the Environmental Protection Agency, or the United States government. Funding information for this article has been deposited with the Crossref Funder Registry.
- Received January 23, 2021.
- Accepted June 30, 2021.
- Copyright ©The authors 2022. For reproduction rights and permissions contact permissions{at}ersnet.org